Alnylam Pharmaceuticals (ALNY) PT Raised to $377 at Wells Fargo
Tweet
Share
E-mailGet Alerts ALNY Hot Sheet
Price: $255.96 --0%
Rating Summary:
29 Buy, 12 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 9 | New: 43
Rating Summary:
29 Buy, 12 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 9 | New: 43
Join SI Premium – FREE
Wells Fargo analyst Derek Archila raised the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $377.00 (from $376.00) while maintaining a Equal Weight rating.
You May Also Be Interested In
- Ocugen, Inc. (OCGN) PT Raised to $10 at H.C. Wainwright
- Rezolute (RZLT) PT Raised to $10 at H.C. Wainwright
- OMV AG (OMV:AV) (OMVKY) PT Raised to EUR65.50 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
